Risk-Based Management of Follicular Lymphoma: Case 2

Video

Risk-Based Management of Follicular Lymphoma

January 2014

  • A 66-year-old male presents with bilateral inguinal and right axillary adenopathy.
  • Past medical history includes hypercholesterolemia managed with simvastatin; moderate hypertension, managed with hydrochlorothiazide/triamterene; history of atrial fibrillation managed with apixaban.
    • Laboratory findings: hemoglobin level 10.2 g/dL, LDH elevated
    • CT scan shows widely disseminated disease, with bulky adenopathy in the pelvis, mesentery, retroperitoneum, supraclavicular region, and aortopulmonary window. The largest lymph node is 9.8 cm.
    • Chest radiography shows small bilateral pleural effusions
    • Bone marrow biopsy shows 70% involvement with FL
    • Excisional biopsy shows grade 2 follicular lymphoma
  • The patient was started on R-CHOP and achieved remission for 19 months at which time he developed an enlarging adenopathy in the pelvis.

October 2015

  • Upon relapse of her disease, the patient was treated with bendamustine/rituximab.
  • He achieved a partial response for close to 6 months.

April 2016

  • The patient reports feeling tired and abdominal fullness.
  • Physical exam remarkable for palpable splenomegaly.
  • PET imaging showed enlargement of pelvic and retroperitoneal nodes and development of several new lesions.
  • The patient was started on idelalisib therapy.
Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
Related Content